madman
Super Moderator
Eric Ruderman, MD, discusses the recent FDA approval of vagus nerve stimulation for rheumatoid arthritis. The approval was based on the findings from the RESET-RA trial, which involved multiple locations, including Northwestern Medicine. Dr. Ruderman provides insights on the trial, which evaluated a stimulation device in patients who did not respond to conventional therapies. The trial observed significant improvements in disease activity with active stimulation when compared to patients who didn’t receive stimulation.
